BASIS OF PRESENTATION, SIGNIFICANT CONCENTRATION AND RISKS (Narrative) (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Total cash at bank including insured amount	$ 146,777,083		$ 146,777,083		$ 129,289,461
Cash, Insured Amount	$ 73,923		$ 73,923		$ 76,101
Customers that individually comprised 10% or more of the total sales	0	0	0	0
Suppliers that comprised 10% or more of the total purchases	0	0	0	0
Customers represented 10% or more of trade receivables	0		0		0
Suppliers that represented more than 10% of accounts payables	0		0		2
Human Albumin [Member]
Major product sales percentage	42.50%	38.70%	40.20%	46.40%
Human Immunoglobulin For Intravenous Injection [Member]
Major product sales percentage	39.40%	42.10%	43.50%	37.40%